Nanostring Technologies, Inc. has been awarded a $12,399 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide master kits and primers. The products will support research efforts at Nanostring's place of performance in Seattle, Washington through December 2023. A firm fixed price was established for this acquisition of molecular diagnostic tools, with no subcontractors involved. This purchase augments NIH/NIAID's ongoing work...
Nanostring Technologies, Inc. has been awarded a firm fixed price purchase order valued at ten thousand two hundred twenty four dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the contract, Nanostring will provide its XT HS HostResponse assay kits and related supplies to support the NIH's infectious disease research efforts. As the prime contractor, Nanostring will deliver four assay kits priced at three thousand three hundred eleven...
This contract award to Nanostring Technologies, Inc. is for the delivery of the company's specialized nCounter RNA analysis systems, reagents, and related consumables to support biomedical research and healthcare programs for the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The $6,100 firm fixed-price purchase order includes the supply of nCounter Analysis Systems, which enable multiplexed digital detection and...
This $93,359 firm fixed-price purchase order was awarded to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract is for the delivery of Nanostring's proprietary nCounter and GeoMx analysis systems, reagents, and consumables to support genomic, molecular, and cellular...
The National Institutes of Health National Institute of Allergy and Infectious Diseases has awarded a firm fixed price purchase order valued at $15,366 to Nanostring Technologies, Inc. to deliver consumable products supporting genomic analysis on the GeoMx Next Generation Sequencing platform. As a manufacturer of life science tools for translational research and molecular diagnostics, Nanostring will provide RNA biological products and consumables tailored to the agency's biomedical...
This is a federal contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The contract, valued at $5,883.00, is a firm fixed-price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) for assay kits. The contract has no set-aside designation. Nanostring has provided a wide range of products and services to various government agencies through past prime and subcontract awards,...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $22,941 firm fixed price purchase order to Nanostring Technologies, Inc. of Seattle, Washington. The contract is for the delivery of RNA consumables to support assay activity. No additional details were provided regarding the specific assays or research being supported. The place of performance is Nanostring's headquarters in Seattle. The period of...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools. The $50,203.50 firm fixed-price purchase order is for the delivery of Nanostring's specialized laboratory equipment, reagents, assays, and testing services to support genomic, molecular, and...
Nanostring Technologies, Inc. has been awarded a $24,900 firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases to provide unspecified products or services in support of the agency's programs. Performance will take place in Seattle, Washington over a one year period concluding in December 2024. No additional details were provided regarding the original solicitation requirements. Nanostring Technologies is the...
This federal contract award to Nanostring Technologies, Inc. is for the provision of the NANOSTRING HUMAN MIRNA ASSAY KIT, valued at $10,789.01. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2015. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms...